Remove Conditions Remove Patients Remove THC
article thumbnail

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Texas: Lawmakers Advance Bill Expanding State’s Medical Cannabis Access Program

NORML

Provisions in the bill open the program to those suffering from chronic pain, among other newly eligible conditions. It also expands the variety of cannabis formulations that may be possessed by patients and significantly increases total number of state-licensed dispensaries that can operate in the state.

Programs 162
article thumbnail

Dronabinol: An FDA-Approved THC Treatment

PrestoDoctor

Dronabinol, commonly known by its brand name Marinol, is an FDA-approved synthetic form of delta-9-tetrahydrocannabinol (THC) the primary psychoactive component found in cannabis. Used in medical settings, Dronabinol offers relief for patients struggling with chemotherapy-induced nausea, vomiting, and appetite loss associated with HIV/AIDS.

article thumbnail

Cannabinoids: THC

FloridaMarijuana.net

Once medical marijuana is ingested, the receptors are opened and the medication begins to provide relief to patients. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions. THC was discovered by Scientist Raphael Mechoulam in the 1960s.

article thumbnail

CBD, THC & CBG for Skin Conditions

Project CBD

For decades, researchers have studied cannabinoids’ ability to treat clinical skin conditions like acne, ulcers, and dermatitis. 3 It’s even possible that cannabinoids taken internally, and not simply via a localized topical, may be able to help — especially if a condition is more widespread.

article thumbnail

How does medical marijuana help patients with Epilepsy?

FloridaMarijuana.net

The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. It is not fully known the genetic origins of epilepsy or if the condition is hereditary. Both THC and CBD bind to receptors in the brain and ultimately block the transmission of pain signals.

Epilepsy 187